Correlation analyses of radiographic progression‐free survival with clinical and health‐related quality of life outcomes in metastatic castration‐resistant prostate cancer: Analysis of the phase 3 VISION trial.

MLA

Morris, Michael J., et al. “Correlation Analyses of Radiographic Progression‐free Survival with Clinical and Health‐related Quality of Life Outcomes in Metastatic Castration‐resistant Prostate Cancer: Analysis of the Phase 3 VISION Trial.” Cancer (0008543X), vol. 130, no. 20, Oct. 2024, pp. 3426–35. EBSCOhost, https://doi.org/10.1002/cncr.35438.

APA

Morris, M. J., de Bono, J., Nagarajah, J., Sartor, O., Wei, X. X., Nordquist, L. T., Koshkin, V. S., Chi, K. N., Krause, B. J., Herrmann, K., Rahbar, K., Vickers, A., Mirante, O., Ghouse, R., Fizazi, K., & Tagawa, S. T. (2024). Correlation analyses of radiographic progression‐free survival with clinical and health‐related quality of life outcomes in metastatic castration‐resistant prostate cancer: Analysis of the phase 3 VISION trial. Cancer (0008543X), 130(20), 3426–3435. https://doi.org/10.1002/cncr.35438

Chicago

Morris, Michael J., Johann de Bono, James Nagarajah, Oliver Sartor, Xiao X. Wei, Luke T. Nordquist, Vadim S. Koshkin, et al. 2024. “Correlation Analyses of Radiographic Progression‐free Survival with Clinical and Health‐related Quality of Life Outcomes in Metastatic Castration‐resistant Prostate Cancer: Analysis of the Phase 3 VISION Trial.” Cancer (0008543X) 130 (20): 3426–35. doi:10.1002/cncr.35438.